The Peptide Hormones Market is expected to register a CAGR of 6.9% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Peptide Hormones Market report covers analysis by Type (Follicle-stimulating Hormone and Luteinizing Hormone, Adrenocorticotropic Hormone, Growth Hormones, Erythropoietin, Insulin); Route of Administration (Parenteral, Oral, Mucosal, Pulmonary, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The report Offers the Value in US$ for the above analysis and segments.
Purpose of the ReportThe report Peptide Hormones Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Peptide Hormones Market Segmentation
Type- Follicle-stimulating Hormone and Luteinizing Hormone
- Adrenocorticotropic Hormone
- Growth Hormones
- Erythropoietin
- Insulin
- Parenteral
- Oral
- Mucosal
- Pulmonary
Strategic Insights
Peptide Hormones Market Growth Drivers- Increasing Prevalence of Hormonal Disorders:
The rising incidence of hormonal disorders such as diabetes, thyroid dysfunction, and growth hormone deficiencies is driving the demand for peptide hormone treatments. As these conditions require ongoing management with hormone replacement therapies, the need for peptide-based treatments continues to grow. - Advancements in Peptide-based Therapeutics:
Ongoing research and development in peptide-based drugs and therapies are expanding the applications of peptide hormones in various medical fields. Innovations in peptide synthesis, drug delivery systems, and targeted therapies are opening new treatment options for a range of diseases, including cancer, metabolic disorders, and cardiovascular conditions, boosting market growth. - Rising Demand for Personalized Medicine:
With the growing trend toward personalized medicine, peptide hormones are increasingly being used in customized treatment regimens. Advances in genetic profiling and biomarkers are allowing healthcare providers to tailor peptide hormone therapies to individual patients' needs, improving treatment efficacy and driving the demand for peptide hormone-based solutions.
- Growth of Peptide-based Cancer Therapies:
Peptide hormones are gaining attention for their potential in cancer treatments, especially in targeted therapies. Researchers are exploring the use of peptide hormones for specific tumor targeting and as part of novel immunotherapies. This trend is expected to increase as the demand for precision medicine and targeted cancer therapies grows. - Integration of Peptides with Drug Delivery Systems:
Advances in drug delivery technologies, such as nanoparticles and controlled-release systems, are enhancing the efficacy of peptide hormones. These systems can improve the bioavailability, stability, and targeted delivery of peptide-based therapies, leading to better patient outcomes and expanded use of peptide hormones in treating various diseases. - Focus on Regenerative Medicine and Anti-Aging Treatments:
Peptide hormones are being increasingly researched for their role in regenerative medicine and anti-aging therapies. The potential of peptides to stimulate growth factors, promote tissue repair, and delay aging-related changes is likely to fuel the demand for peptide-based treatments in regenerative medicine, offering new avenues for market growth.
- Expanding Applications in Metabolic Disorders:
The growing prevalence of metabolic disorders like obesity, diabetes, and insulin resistance presents an opportunity for peptide hormones in treatment development. Peptide-based therapies that regulate insulin production, appetite, and metabolism could become key solutions for managing these chronic conditions, driving demand in the market. - Increasing Use in Anti-Aging and Cosmetic Treatments:
Peptide hormones are gaining popularity in the field of dermatology and cosmetic treatments for their potential anti-aging benefits. Peptides like human growth hormone (HGH) are being explored for skin regeneration, wrinkle reduction, and overall rejuvenation, presenting a lucrative opportunity in the growing global skincare and anti-aging market. - Advancements in Personalized Medicine:
With the rise of personalized medicine, peptide hormone therapies can be tailored to individual patients based on genetic profiles and specific health conditions. This shift toward more customized treatments opens up new opportunities for the peptide hormones market, as it enhances the effectiveness of therapies and caters to the growing demand for individualized healthcare solutions.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Peptide Hormones Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Peptide Hormones Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The major factors driving the Peptide Hormones Market are Increase in Gastrointestinal Disorders, Growing focus on preventive healthcare, and Improved Diagnostic Technology
The key future trends of the market are Transition Towards Point-of-Care Testing, Introduction to Laboratory Automation, and Availability of Rapid and Accurate Results
The leading players operating in the Peptide Hormones Market include BioPartners, Boehringer Ingelheim GmbH, Eli Lily and Company, Innovate Biopharmaceuticals, Merck KGaA, Novo Nordisk, Pfizer, Inc., F. Hoffman-La-Roche Ltd., Sanofi.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peptide Hormone Market - By Type
1.3.2 Peptide Hormone Market - By Route of Administration
1.3.3 Peptide Hormone Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PEPTIDE HORMONE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PEPTIDE HORMONE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. PEPTIDE HORMONE MARKET - GLOBAL MARKET ANALYSIS
6.1. PEPTIDE HORMONE - GLOBAL MARKET OVERVIEW
6.2. PEPTIDE HORMONE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PEPTIDE HORMONE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. FOLLICLE-STIMULATING HORMONE AND LUTEINIZING HORMONE
7.3.1. Overview
7.3.2. Follicle-stimulating Hormone and Luteinizing Hormone Market Forecast and Analysis
7.4. ADRENOCORTICOTROPIC HORMONE
7.4.1. Overview
7.4.2. Adrenocorticotropic Hormone Market Forecast and Analysis
7.5. GROWTH HORMONES
7.5.1. Overview
7.5.2. Growth Hormones Market Forecast and Analysis
7.6. ERYTHROPOIETIN
7.6.1. Overview
7.6.2. Erythropoietin Market Forecast and Analysis
7.7. INSULIN
7.7.1. Overview
7.7.2. Insulin Market Forecast and Analysis
8. PEPTIDE HORMONE MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. PARENTERAL
8.3.1. Overview
8.3.2. Parenteral Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
8.5. MUCOSAL
8.5.1. Overview
8.5.2. Mucosal Market Forecast and Analysis
8.6. PULMONARY
8.6.1. Overview
8.6.2. Pulmonary Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. PEPTIDE HORMONE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Peptide Hormone Market Overview
9.1.2 North America Peptide Hormone Market Forecasts and Analysis
9.1.3 North America Peptide Hormone Market Forecasts and Analysis - By Type
9.1.4 North America Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.1.5 North America Peptide Hormone Market Forecasts and Analysis - By Countries
9.1.5.1 United States Peptide Hormone Market
9.1.5.1.1 United States Peptide Hormone Market by Type
9.1.5.1.2 United States Peptide Hormone Market by Route of Administration
9.1.5.2 Canada Peptide Hormone Market
9.1.5.2.1 Canada Peptide Hormone Market by Type
9.1.5.2.2 Canada Peptide Hormone Market by Route of Administration
9.1.5.3 Mexico Peptide Hormone Market
9.1.5.3.1 Mexico Peptide Hormone Market by Type
9.1.5.3.2 Mexico Peptide Hormone Market by Route of Administration
9.2. EUROPE
9.2.1 Europe Peptide Hormone Market Overview
9.2.2 Europe Peptide Hormone Market Forecasts and Analysis
9.2.3 Europe Peptide Hormone Market Forecasts and Analysis - By Type
9.2.4 Europe Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.2.5 Europe Peptide Hormone Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Peptide Hormone Market
9.2.5.1.1 Germany Peptide Hormone Market by Type
9.2.5.1.2 Germany Peptide Hormone Market by Route of Administration
9.2.5.2 France Peptide Hormone Market
9.2.5.2.1 France Peptide Hormone Market by Type
9.2.5.2.2 France Peptide Hormone Market by Route of Administration
9.2.5.3 Italy Peptide Hormone Market
9.2.5.3.1 Italy Peptide Hormone Market by Type
9.2.5.3.2 Italy Peptide Hormone Market by Route of Administration
9.2.5.4 Spain Peptide Hormone Market
9.2.5.4.1 Spain Peptide Hormone Market by Type
9.2.5.4.2 Spain Peptide Hormone Market by Route of Administration
9.2.5.5 United Kingdom Peptide Hormone Market
9.2.5.5.1 United Kingdom Peptide Hormone Market by Type
9.2.5.5.2 United Kingdom Peptide Hormone Market by Route of Administration
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Peptide Hormone Market Overview
9.3.2 Asia-Pacific Peptide Hormone Market Forecasts and Analysis
9.3.3 Asia-Pacific Peptide Hormone Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.3.5 Asia-Pacific Peptide Hormone Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Peptide Hormone Market
9.3.5.1.1 Australia Peptide Hormone Market by Type
9.3.5.1.2 Australia Peptide Hormone Market by Route of Administration
9.3.5.2 China Peptide Hormone Market
9.3.5.2.1 China Peptide Hormone Market by Type
9.3.5.2.2 China Peptide Hormone Market by Route of Administration
9.3.5.3 India Peptide Hormone Market
9.3.5.3.1 India Peptide Hormone Market by Type
9.3.5.3.2 India Peptide Hormone Market by Route of Administration
9.3.5.4 Japan Peptide Hormone Market
9.3.5.4.1 Japan Peptide Hormone Market by Type
9.3.5.4.2 Japan Peptide Hormone Market by Route of Administration
9.3.5.5 South Korea Peptide Hormone Market
9.3.5.5.1 South Korea Peptide Hormone Market by Type
9.3.5.5.2 South Korea Peptide Hormone Market by Route of Administration
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Peptide Hormone Market Overview
9.4.2 Middle East and Africa Peptide Hormone Market Forecasts and Analysis
9.4.3 Middle East and Africa Peptide Hormone Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.4.5 Middle East and Africa Peptide Hormone Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Peptide Hormone Market
9.4.5.1.1 South Africa Peptide Hormone Market by Type
9.4.5.1.2 South Africa Peptide Hormone Market by Route of Administration
9.4.5.2 Saudi Arabia Peptide Hormone Market
9.4.5.2.1 Saudi Arabia Peptide Hormone Market by Type
9.4.5.2.2 Saudi Arabia Peptide Hormone Market by Route of Administration
9.4.5.3 U.A.E Peptide Hormone Market
9.4.5.3.1 U.A.E Peptide Hormone Market by Type
9.4.5.3.2 U.A.E Peptide Hormone Market by Route of Administration
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Peptide Hormone Market Overview
9.5.2 South and Central America Peptide Hormone Market Forecasts and Analysis
9.5.3 South and Central America Peptide Hormone Market Forecasts and Analysis - By Type
9.5.4 South and Central America Peptide Hormone Market Forecasts and Analysis - By Route of Administration
9.5.5 South and Central America Peptide Hormone Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Peptide Hormone Market
9.5.5.1.1 Brazil Peptide Hormone Market by Type
9.5.5.1.2 Brazil Peptide Hormone Market by Route of Administration
9.5.5.2 Argentina Peptide Hormone Market
9.5.5.2.1 Argentina Peptide Hormone Market by Type
9.5.5.2.2 Argentina Peptide Hormone Market by Route of Administration
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PEPTIDE HORMONE MARKET, KEY COMPANY PROFILES
11.1. BIOPARTNERS
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOEHRINGER INGELHEIM GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELI LILY AND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. INNOVATE BIOPHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MERCK KGAA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVO NORDISK
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. F. HOFFMAN-LA-ROCHE LTD.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANOFI
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TARIX PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. BioPartners
2. Boehringer Ingelheim GmbH
3. Eli Lily and Company
4. Innovate Biopharmaceuticals
5. Merck KGaA
6. Novo Nordisk
7. Pfizer, Inc.
8. F. Hoffman-La-Roche Ltd.
9. Sanofi
10. Tarix Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For